援助如何运作
通过无与伦比的全方位服务便利性，简化患者的专业药房体验
-
1. 检查您的保险范围/福利验证
我们的专业出纳员团队会找到最佳的保险途径，以最大程度地减少自付费用。
-
2. 将处方转移到 AmeriPharma®
我们与您之前的药房或处方人员合作来处理您的处方，使过渡变得快速而简单。
-
3. 事先授权
我们的专家团队将在 24 至 72 小时内获得您保险公司的批准。
-
4. 共付额援助和经济援助
我们确保患者获得经济援助，并降低共付额、自付费用和高额免赔额。迄今为止，AmeriPharma® 专科护理已为患者争取到 1TP4.4755 亿美元的经济援助。
-
5.护理协调
AmeriPharma® 在安排和协调我们的专业护士为您进行家庭输液时，会将您的日程安排和家庭环境放在首位。
-
6. 交付协调
药品始终严格遵守运输的具体要求。次日或隔夜冷链配送将根据您的时间安排进行协调。
What Is Keytruda?
Keytruda is the trade name for pembrolizumab, an intravenous medication for treating several cancers among adults and children. Keytruda belongs to a family of immunotherapies called monoclonal antibodies. Physicians prescribe this medication in three ways:
- Monotherapy: As a standalone treatment
- Combination Therapy: As simultaneous treatment with other cancer medications
- Adjuvant Therapy: As a follow-on treatment to kill surviving cancer cells after a successful course with another medication
Keytruda 如何工作？
The human immune system has evolved to detect, kill and remove many types of cancer cells. However, some cancers can alter their chemical signatures, evade detection, and grow unmolested. Keytruda acts by blocking the pathway cancer cells use to remain undetected. Since the malignant cells are now exposed, the immune system is better able to target, destroy and remove them.
What Conditions Does Keytruda Treat?
Keytruda has earned 食品和药物管理局 approval for 19 types of cancer.
乳腺癌
With inoperable breast cancers, physicians use Keytruda as a component in combination therapies. Where surgery is possible, doctors use this medication as a postoperative adjuvant treatment.
皮肤癌
For the most serious type of skin cancer known as melanoma, physicians prescribe Keytruda as either a monotherapy or adjuvant. With cutaneous squamous cell carcinoma and Merkel cell carcinoma, doctors use Keytruda as a monotherapy.
肺癌
With non-small cell lung cancer (NSCLC), doctors usually combine Keytruda with chemotherapy agents such as pemetrexed, carboplatin or paclitaxel. Keytruda may also be used as monotherapy in those patients who express a protein called PD-L1 on their cancer cells. It is also used as an adjuvant following resection of specific tumors.
淋巴瘤
With blood cancers such as classical Hodgkin’s lymphoma or primary mediastinal large B-cell lymphoma, doctors use Keytruda as a monotherapy after other treatments have failed.
Organ Cancers
With cancers of the bladder, liver, colon, and rectum, physicians use Keytruda as a monotherapy. For stomach cancer, esophageal carcinoma, endometrial carcinoma, cervical cancer, and renal cell carcinoma, doctors use Keytruda as a monotherapy or in combination therapy, depending on individual patient circumstances.
共付额和经济援助
AmeriPharma® 特药药房减轻了患者及其家人的经济负担
-
先进的软件可以定位资金来源，为您匹配高额的基金会项目
-
我们的一位共付额援助专家将协助您完成申请流程
-
自动更新信息将发送给您和您的医生，告知您资金状况
Dosing Recommendations
Patients receive Keytruda doses as intravenous infusions in clinical settings. Infusion sessions usually last about 30 minutes. For adults, the recommended dose is 200 mg every 3 weeks or 400 mg every 6 weeks.
With pediatric cancers, the recommended dose is 2 mg for each kg of patient bodyweight. 200 mg is the maximum pediatric dose and the infusion is given every 3 weeks.
When patients receive other chemotherapy agents at the same appointment, Keytruda infusions should come first.
Time Limits
For all cancer types, Keytruda should be discontinued if the disease progresses or if treatment becomes toxic to the patient. Your doctor will decide the length of the treatment course as it may vary depending on several patient-specific factors. The maximum duration of treatment is 24 months for all cancer types except melanoma. Patients who take Keytruda for melanoma may continue treatment indefinitely.
接受保险
我们接受 Medicare、跨州 Medicaid、Medi-Cal、Blue Shield 以及大多数私人保险。请致电我们，了解更多您的保险信息。
